Camber Spine Receives FDA Clearance for SPIRA-A Integrated Fixation System 
Volpara Solutions Celebrates 10 Years of Striving to Save Families from Breast Cancer
WELLINGTON, New Zealand, April 4, 2019 /PRNewswire/ -- Celebrating its 10th Anniversary in 2019, Volpara Solutions remains committed to helping breast imaging...
Synchron Initiates First-ever Clinical Trial to Evaluate Thought-to-Text™ Brain-Computer Interface Technology in Patients with Severe Paralysis
SAN FRANCISCO and NEW YORK and MELBOURNE, Australia, April 8, 2019 /PRNewswire/ -- Synchron, Inc. today announced the initiation of the...
The University of Iowa Carver College of Medicine Improves Student Exam Scores with Gale Interactive: Human Anatomy
FARMINGTON HILLS, Mich. and IOWA CITY, Iowa, April 8, 2019 /PRNewswire/ -- The University of Iowa Carver College of Medicine has...
Alzheimer’s Research About to Reach Crushing Speeds
REDMOND, Wash., April 8, 2019 /PRNewswire/ -- On April 13 thousands will join the "Megathon" event from home and in public...
Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives
LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company...
Identifying Grass Pollen That Gets Up Your Nose
First results of a major three-year project to analyze airborne grass pollen LONDON, UK / ACCESSWIRE / April 8, 2019...
Easton Provides Update on the Closing of its Agreement To Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
TORONTO, ON / ACCESSWIRE / April 8, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides update on the closing...
Virpax(R) Pharmaceuticals Announces R&D Collaborative Initiative with Kannaba Technologies
Companies to Combine Cutting-Edge Delivery Technologies, Coupled with Advanced Computational Capabilities and Robotics for Development of Innovative Cannabinoid-Based Biopharmaceuticals MALVERN,...
EFX Laboratories Commences Commercial Capsule Sales Through Strategic Partnership
VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
ORYZON to Present First in Human Efficacy Data with Vafidemstat at the 27th European Congress of Psychiatry in Warsaw
Efficacy data from the REIMAGINE Phase IIa basket trial's Borderline Personality Disorder (BPD) cohort Vafidemstat is an active compound in...
Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman to Board of Directors
Mr. Goldman also joins newly formed Board special committee established to evaluate strategic options LIVINGSTON, NJ / ACCESSWIRE / April...
Oncolytics Biotech(R) Announces First Patient Treated in Company’s AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer
- Study to generate comprehensive biomarker data by breast cancer sub-type to support phase 3 registration program - Interim data...
EVITRADE Signs LOI with Medical Delivery App and Update on Time-Release Drug Delivery System Joint Venture
VANCOUVER, BC / ACCESSWIRE / April 5, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Year Ended 31 December 2018 and 2019 Guidance
Parnell Delivers 39% Revenue Growth and a $6.5 Million Improvement in EBITDA in 2018 Compared to 2017, Returns to NPAT...
Frank Magliochetti on the Potential of Pharmacogenomic Testing to Reduce Healthcare Costs
LAWRENCE, MA / ACCESSWIRE / April 4, 2019 / Healthcare spending in the United States reached $3.5 trillion in 2017,...
Bankole A. Johnson, M.D., Chief Medical Officer of Adial Pharmaceuticals Delivers Keynote Lecture; Receives Prestigious American Society of Addiction Medicine Award
Lecture to focus on pharmacogenic treatment personalization for alcohol use disorder CHARLOTTESVILLE, VA / ACCESSWIRE / April 4, 2019 /...
Dynatronics to Attend the NDC Exhibition 2019
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / April 4, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of athletic training,...
DECN Hails Completion of Its Genultimate! TBG Panacea System, 3rd Party Testing to Begin in Next 7 Days, Clinical Trials Testing to Begin in May
Equity Fund in Stealthy Move Tried to Gain Control of DECN In March, Just as a Big Box Was in...
Alimera Sciences Announces Expansion of Leadership Team with Appointment of Samer Kaba, MD as Chief Medical Officer
ATLANTA, GA / ACCESSWIRE / April 4, 2019 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization...
Oncolytics Biotech(R) to Host Key Opinion Leader Meeting on the Emerging Role of Biomarkers and Oncolytic Viruses in the Treatment of Cancer
Meeting and webcast scheduled for Thursday, April 11 in New York City CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE...